GLP1R and diabetes mellitus: Diabetes-severity model (GLP-1 RA Users vs Non–GLP-1 RA Users): GLP-1 RA Users had a lower risk of all-cause death (HR 0.363, 95% CI 0.355–0.370) and a higher risk of the composite outcome (HR 1.047, 95% CI 1.007–1.088) (Supplementary Table 5).